ArticleMatrix biology : journal of the International Society for Matrix Biology2026
Oligodendrocyte integrin-β1 regulates blood-brain barrier and remyelination in hemorrhagic brain.
Article in Matrix biology : journal of the International Society for Matrix Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Intracerebral hemorrhage (ICH) causes high rates of mortality and long-term disability, but there are no effective treatments currently. Two key pathologies of ICH are blood-brain barrier (BBB) damage and white matter injury. Previous studies show that oligodendrocytes (OLs) regulate BBB integrity and (re)myelination via the extracellular matrix (ECM). The receptors that mediate these functions, however, remain incompletely understood. Here, we investigated the function of OL-derived integrin-β1 under both homeostatic and ICH conditions using conditional knockout mice. The mutant mice were grossly normal with intact BBB and OL maturation/myelination under homeostatic conditions. After ICH, however, these mutants exhibited exacerbated brain injury, including larger hematoma volume, elevated brain edema, aggravated axonal injury, enhanced BBB damage, compromised OL differentiation/maturation, impaired remyelination, and worsened neurological dysfunction. Subsequent studies revealed that the enhanced BBB injury was mediated by both paracellular and transcellular mechanisms and associated with pericyte defects. These findings demonstrate that OL-derived integrin-β1 is dispensable under homeostatic conditions but strictly required for BBB repair and remyelination following hemorrhagic stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.